Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
4.1%
1w
11.8%
1m
5.9%
3m
9.8%
6m
38.1%
1y
10.3%
all
14.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,394 4.1%
1,238
1,614
Company Overview
Sales
1,108 Cr
Growth: -8.7%
Profit after Tax
275 Cr
Growth: 5.5%
Mid Cap
14,585 Cr
P/E: 53.4x
Industry P/E: 35.1x
Fundamentals
Sales (Cr) ₹ 1,108
Growth -8.7%
EBITDA 35.0%
P/S 13.2x
Dividend 0.6%
P/E 53.4x
Book Value ₹ 198
PEG Ratio -6.2x
ROE 13.8%
P/B 7.0x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (24 Indices) view more
Followers (1)
varsha96